NASDAQ:CYRN Cyren (CYRN) Stock Price, News & Analysis → This consistently signaled gains of 453%... 610%... and even 1036%... (From Insiders Exposed) (Ad) Free CYRN Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$0.21▼$0.9252-Week Range N/AVolume1.15 million shsAverage Volume1.43 million shsMarket Capitalization$1.70 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Cyren alerts: Email Address Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now About Cyren Stock (NASDAQ:CYRN)CYREN Ltd. engages in the provision of cloud delivered Software-as-a-Service cybersecurity solutions that protect businesses, employees and customers against threats from email, files, and the web. It operates through the following geographical segments: Israel, United States, Germany and Other. Its products include inbox security for office 365, threat indepth, and incident response service The company was founded by Amir Lev, Gideon Mantel, and Nahum Sharfman on February 10, 1991 and is headquartered in Herzliya, Israel.Read More Ad WealthPressA lot of people are making this costly mistakeYou may have heard the saying “options are risky” … And, they can be. But only if you use them the way a lot of folks do. A lot of people think of BUYING speculative options when they talk about options. And BUYING low probability, speculative options is definitely risky… It’s how some folks leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. Click here to jump in on the next one CYRN Stock News HeadlinesMay 16, 2023 | marketwatch.comTechMediaBreaks - Data443 Risk Mitigation Inc. (ATDS) Announces Strategic Acquisition of Select Assets of Israel-Based Cyren Ltd.February 23, 2023 | investorplace.comWhy Is Cyren (CYRN) Stock Down 27% Today?March 29, 2024 | DTI (Ad)Warning: this could blow your mindBuckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…February 22, 2023 | finance.yahoo.comCyren Announces Nasdaq Delisting DeterminationFebruary 22, 2023 | finance.yahoo.comCyren Announces LiquidationFebruary 22, 2023 | investorplace.comWhy Is Cyren (CYRN) Stock Up 43% Today?February 21, 2023 | finance.yahoo.comCyren Announces Non-Binding LOI to Sell Iceland-Based Anti-Malware Business AssetsFebruary 16, 2023 | tmcnet.comNetSTAR Offers a Threat Intelligence Feed Replacement for Cyren's OEM CustomersMarch 29, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.February 1, 2023 | finance.yahoo.comCyren Announces Global Reduction in Force; Liquidity ChallengesJanuary 22, 2023 | bbc.comRutter points to Marsch influenceNovember 16, 2022 | finanznachrichten.deCyren Ltd: Cyren Announces Third Quarter 2022 Financial ResultsNovember 16, 2022 | apnews.comCyren: Q3 Earnings SnapshotNovember 16, 2022 | seekingalpha.comCyren Ltd (CYRN) Q3 2022 Earnings Call TranscriptNovember 15, 2022 | finance.yahoo.comCyren Announces Third Quarter 2022 Financial ResultsNovember 9, 2022 | reuters.comCYRN.A - Cyren Ltd | Stock Price & Latest News | ReutersNovember 2, 2022 | finance.yahoo.comCyren Schedules Third Quarter 2022 Earnings Release for Monday, November 14, 2022October 24, 2022 | reuters.comCYRN.PH - Cyren Ltd | Stock Price & Latest News | ReutersOctober 19, 2022 | benzinga.comForetrace Appoints Industry Veteran as President and COO - CYREN (NASDAQ:CYRN) - BenzingaOctober 10, 2022 | seekingalpha.comSOBR Safe tops tech gainers; ACM Research tops losers - Seeking AlphaOctober 8, 2022 | streetinsider.comeSentire Adds Cybersecurity Industry Heavyweights to its Board of Directors - StreetInsider.comSeptember 22, 2022 | marketscreener.comCyren : Statement of Changes in Beneficial Ownership - Form 4 - Marketscreener.comSeptember 15, 2022 | streetinsider.comCyren Launches Hybrid Analyzer for Unmatched Speed and Scale of Malware Analysis - StreetInsider.comSeptember 13, 2022 | finance.yahoo.comCyren Launches Hybrid Analyzer for Unmatched Speed and Scale of Malware AnalysisSeptember 6, 2022 | marketscreener.comCYREN LTD. : Submission of Matters to a Vote of Security Holders (form 8-K) - Marketscreener.comAugust 17, 2022 | finance.yahoo.comCyren Inbox Security Achieves SOC 2 Type 2 ComplianceAugust 16, 2022 | finance.yahoo.comCyren Announces Second Quarter 2022 Financial ResultsSee More Headlines Receive CYRN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cyren and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/15/2021Today3/28/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorComputer and Technology Industry Prepackaged software Sub-IndustryN/A Current SymbolNASDAQ:CYRN CUSIPN/A CIK1084577 Webwww.cyren.com Phone(729) 863-6888Fax972-9894-8214Employees200Year Founded1991Profitability EPS (Most Recent Fiscal Year)($5.34) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-23,040,000.00 Net Margins-123.96% Pretax Margin-94.37% Return on Equity-206.16% Return on Assets-48.72% Debt Debt-to-Equity Ratio2.30 Current Ratio1.29 Quick Ratio1.29 Sales & Book Value Annual Sales$31.19 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$3.05 per share Price / BookN/AMiscellaneous Outstanding Shares7,780,000Free Float7,539,000Market Cap$1.70 million OptionableNot Optionable Beta0.83 Social Links 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesBrett Michael JacksonChief Executive Officer & DirectorBoris BogodVice President-Global Cloud OperationsJeffrey R. DauerChief Financial Officer & Accounting OfficerIsaac DvirSenior Vice President-EngineeringLior KohaviChief Strategy Officer & EVP-Advanced SolutionsKey CompetitorsMy SizeNASDAQ:MYSZBIO-key InternationalNASDAQ:BKYITaopingNASDAQ:TAOPInfobirdNASDAQ:IFBDAmesiteNASDAQ:AMSTView All Competitors CYRN Stock Analysis - Frequently Asked Questions How were Cyren's earnings last quarter? Cyren Ltd. (NASDAQ:CYRN) announced its quarterly earnings data on Monday, November, 15th. The technology company reported ($0.06) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.06). The technology company had revenue of $7.46 million for the quarter. Cyren had a negative net margin of 123.96% and a negative trailing twelve-month return on equity of 206.16%. What other stocks do shareholders of Cyren own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cyren investors own include Actinium Pharmaceuticals (ATNM), Inovio Pharmaceuticals (INO), Onconova Therapeutics (ONTX), OPKO Health (OPK), Vaxart (VXRT), Biocept (BIOC), iBio (IBIO), MEI Pharma (MEIP), VBI Vaccines (VBIV) and Does Cyren have any subsidiaries? The following companies are subsidiares of Cyren: Authentium, Cyren Gesellschaft mbH, Cyren Iceland hf, Cyren Inc., Cyren UK Ltd., FRISK Software International, Wingtra, and eleven GmbH.Read More This page (NASDAQ:CYRN) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryOnly a fool would buy Nvidia today… Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyren Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.